Simple Summary Surgery is the only curative treatment for localized disease in
retroperitoneal sarcoma (RPS). Frontline extended surgery, or compartmental surgery, is a …

Simple Summary The treatment of retroperitoneal sarcomas poses significant challenges
due to their infrequency, clinical and histologic heterogeneity, and unique anatomical …

Purpose Neoadjuvant radiation therapy (RT) with standard techniques (ST) offers a modest
benefit in retroperitoneal sarcoma (RPS). As the high-risk region (HRR) at risk for a positive …

Background In primary localised resectable retroperitoneal sarcoma (RPS), loco-regional
and distant relapse occur frequently despite optimal surgical management. The role of …

MG 37 preslozeno.indd Page 1 218 ORIGINAL ARTICLE Mid-term outcomes in the treatment of
retroperitoneal sarcomas: a 12-year single-institution experience Georgios-Ioannis Verras1 …

Background Retroperitoneal liposarcoma (RPLS) is a specific soft tissue sarcoma with a
high recurrence rate. The short isoform of transient receptor potential cation channel …

While surgery is the mainstay of treatment for localised retroperitoneal sarcoma, the use of
radiotherapy (RT) remains controversial. This systematic review aimed to evaluate the role …

Background Primary retroperitoneal sarcoma (RPS) comprises over 70 histologic subtypes,
yet there are limited studies that have developed prognostic nomograms for RPS patients to …

Background Neoadjuvant radiotherapy (NRT) for resectable retroperitoneal sarcoma (RPS)
has been shown to be systematically feasible. Whether NRT has equivalent or better clinical …

Background Retroperitoneal sarcoma (RPS)-specific nomograms provide estimates of
survival and recurrence risk following resection in the individual patient. The effect of …